Form 4 for STE Steris
Accepted 2024-11-27 00:00:00 ET · period of report 2024-11-25 · accession 0000950170-24-131534 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-27 | 2024-11-25 | STE | Majors Cary L | SVP, Pres, Healthcare | S - Sale | $217.32 | -1,682 | 11.4K | -13% | -$365.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2024-11-25 | S | D | 1,682 | $217.32 | 11,372 | D | — | — | (F1) Price reflects a weighted average sale price for multiple transactions ranging from $217.32 to $217.40 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of ordinary shares sold at each separate price. (F2) As of November 27, 2024, 9,872 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,964 on June 2, 2025; 692 on October 1, 2025; 2,697 on June 1, 2026; 2,140 on June 2, 2026 and 2,379 on June 4, 2027. |